(Boursier.com) — The Group Berkem, a leading player in plant-based chemistry, announces its half-year results for the year ended June 30 and approved by the Board of Directors on September 28. Half-year sales came out at E28.1 million, up 11.5% with sustained growth in the order book. The EBITDA margin is down due to the rise in raw material prices, gradually covered by a price increase initiated from May 2022. The Group’s net income nevertheless shows an increase of 37.2% to 1 .9 ME as of June 30, 2022.
Olivier FAHY, Chairman and CEO of Groupe Berkem, said: “The results we generated over the period demonstrate the full resilience of our model, based on healthy organic growth and positioning in niche markets with high added value. a declining EBITDA, mainly due to the price inflation we are facing on all of our raw materials, we made the choice very early on to apply price increases to our products which should eventually neutralize This first half was also an opportunity to make numerous commercial investments that will contribute to our future organic growth. our net income. By combining this strategy with the financing of EUR 50 million that we obtained at the end of July, Groupe Berkem is able to Pursue its selective acquisition strategy over the short and medium term.”
Next financial publication: Q3 2022 revenue: October 20, 2022 (after market close).
©2022 Boursier.com